Dividend stocks like Ford and Pfizer offer passive income, but it’s crucial to assess their ability to cover and potentially increase dividends. Ford’s yield is 4.5%, Pfizer’s is 6.9%. Ford has faced challenges but generated $5.7 billion in free cash flow; Pfizer’s path is uncertain post-COVID peak, with lower revenue guidance for 2026. Ultimately, both companies have pros and cons, with Pfizer slightly edging out due to its track record and commitment to dividends. Investors should consider these factors before investing.

Read more at Yahoo Finance: Better Dividend Stock: Ford vs. Pfizer